Saturday, November 6, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0191
Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS) – 30-months Interim Analysis of the RELIANCE Registry
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0050
Integrative Analysis of mRNAs to Identify Sex Differences in Th-17 Mediated Inflammation in Ankylosing Spondylitis
Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)- 8:30AM-10:30AM
-
Abstract Number: 0127
Interleukin 1 Receptor Antagonist (IL-1Ra) Variable Number of Tandem Repeat (VNTR) Polymorphism in Fibromyalgia Patients in South India
Fibromyalgia & Other Clinical Pain Syndromes Poster (0118–0127)- 8:30AM-10:30AM
-
Abstract Number: 0030
Interleukin-9 Enhances the Osteoclastogenesis in Rheumatoid Arthritis
RA – Etiology & Pathogenesis Poster (0011–0045)- 8:30AM-10:30AM
-
Abstract Number: 0430
Interstitial Lung Disease in ANCA-Associated Vasculitis: Associated Factors and Outcomes
Vasculitis – ANCA-Associated Poster (0414–0436)- 8:30AM-10:30AM
-
Abstract Number: 0219
Intra-Articular Mineralization on Knee CT and Risk of Cartilage Loss: The Multicenter Osteoarthritis Study
Osteoarthritis – Clinical Poster I (0210–0224)- 8:30AM-10:30AM
-
Abstract Number: 0023
Investigating Temporal Changes in Pregnancy Among Women with Rheumatoid Arthritis and Healthy Women Using Co-expression Network Analysis
RA – Etiology & Pathogenesis Poster (0011–0045)- 8:30AM-10:30AM
-
Abstract Number: 0250
Is There a Need for a New Classification Criteria in Juvenile Spondyloarthritis?
Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)- 8:30AM-10:30AM
-
Abstract Number: 0400
Item Development for the Assessment of Systemic Sclerosis-associated Raynaud’s Phenomenon (ASRAP) Questionnaire
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0401
Item Reduction for the Assessment of Systemic Sclerosis-associated RAynaud’s Phenomenon (ASRAP) Questionnaire Using Data from the International Multicentre ASRAP Validation Study
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0195
JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s Disease
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0029
JAK1 Regulates Autophagy and Reinforces the Inflammatory and Autoimmune Potentials in Rheumatoid Arthritis Synovial Fibroblasts
RA – Etiology & Pathogenesis Poster (0011–0045)- 8:30AM-10:30AM
-
Abstract Number: 0259
JIA Diagnoses and Trends from 2006-2019: Has the U.S. ICD-9-to-ICD-10 Transition Created Coding Artifacts?
Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)